Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used the third quarter to refocus their ...
Strengthened balance sheet with private placement of up to $100 million to advance CMP-002, a first-in-class treatment for SYNGAP1-related ...
Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to orphan drugs, and part of Duchesnay Pharmaceutical Group (DPG), winner of the 2024 Life ...
Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to orphan drugs, and ...
The diesel engine will remain the preferred powertrain in agricultural machinery for many years to come. Renewable synthetic ...
With an investment of nearly $39mln, the facility aims to produce 10,000 tons of chlorine tablets and granules and 10,000 ...
Dr Mohammed Ali says you can look for signs that bad breath in the morning is something more serious and needs to be ...
Learn why cats stop using the litter box, how to choose the right litter, and simple cleaning tips to keep your cat healthy ...
Chronic kidney disease develops silently. Kidneys filter waste, but when they weaken, toxins build up. This impacts the heart, bones, and blood. Early detection is crucial. Managing blood pressure and ...
Antidepressants show clinically significant and highly heterogeneous effects on cardiometabolic parameters, weight, and blood ...
Endo's glycerol phenylbutyrate is the first and currently the only FDA-approved generic version of RAVICTI (R) available in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results